Rachael Aderonke Ayo-Lawal

Rachael Aderonke Ayo-Lawal

Auto-generated profile, based on publicly available information

Rachael Aderonke Ayo-Lawal

Science, Policy, & Innovation Studies Department, National Centre for Technology Management, Obafemi Awolowo University, Ile-Ife, Nigeria

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2022 in Humanities and Social Sciences Communications
Verified
Journal Article
Open access
PDF file
AEAbiodun Egbetokun
Abiodun Egbetokun
AOAdedayo Olofinyehun
Adedayo Olofinyehun
MSMaruf Sanni
Maruf Sanni
AAAderonke Ayo-Lawal
Aderonke Ayo-Lawal
OOOmolayo Oluwatope
Omolayo Oluwatope
UYUtieyineshola Yusuff
Utieyineshola Yusuff
Nigeria has a very large research system, with nearly 200 universities that employed more than 60,000 academic staff at the end of 2019. The country is also one of Africa’s largest producers of scientific research across all disciplines, surpassed only by South Africa and Egypt. In the social sciences, in particular, Nigeria is Africa’s second-largest producer of published research, after South Africa. However, the country’s social science research (SSR) production does not match the size of its SSR system. Using mixed methods, we come up with two important reasons for this: (i) research inputs are low, mainly because research is poorly funded and researchers devote too little time to research as a result of poor organisational climate, and (ii) the research support system is weak. No single institution currently has a clear mandate to centrally coordinate SSR in Nigeria. Consequently, research efforts are often duplicated and the limited research resources are spread too thin. Moreover, logistical support for research is missing or inefficient in most organisations. Therefore, improving research productivity in the country would require much stronger research coordination and wide-ranging improvements in the research climate.

8 November 2020 in Food Research
Verified
Journal Article
Closed access
RAR.A. Ayo-Lawal
R.A. Ayo-Lawal
Nicole Remaliah Samantha SibuyiNicole Remaliah Samantha Sibuyi
Nicole Remaliah Samantha Sibuyi
OEOKOBI EKPO
OKOBI EKPO
MMMervin Meyer
Mervin Meyer
OOO. Osoniyi
O. Osoniyi
Some fermented foods are reported to possess anti-cancer properties. Fermented African locust bean seeds is a condiment prepared from fermentation of Parkia biglobosa. It has been reportedly functional for various medicinal activities but not anti-cancer. The cytotoxic and apoptosis-inducing properties of the aqueous extract of the condiment were investigated in human cancer - hepatocellular (Hep-G2) and cervical (HeLa) and noncancer cell lines. Cytotoxicity was evaluated using the 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyl tetrazolium bromide (MTT) and clonogenic cell survival assays. Apoptotic cell death and DNA fragmentation were also investigated. The results revealed cytotoxicity to both cell lines in a dose-dependent manner (P < 0.05) and selective activities between cancer and non-cancer cells. The IC50 values were 1.3 and 0.5 mg/mL for Hep-G2 and HeLa cells respectively. Furthermore, the extract induced apoptotic cell death in only Hep -G2 (73.03±0.73) cells. The morphologic photomicrographs correlated well with other findings, indicating the cell-specific cytotoxicity of the condiment

2 March 2020 in Journal of Dietary Supplements
Verified
Journal Article
Closed access
RARachael Aderonke Ayo-Lawal
Rachael Aderonke Ayo-Lawal
OOOmolaja Osoniyi
Omolaja Osoniyi
Nicole Remaliah Samantha SibuyiNicole Remaliah Samantha Sibuyi
Nicole Remaliah Samantha Sibuyi
MMMervin Meyer
Mervin Meyer
OEOKOBI EKPO
OKOBI EKPO
The anti-cancer activities of many fermented foods and beverages are now scientifically established. Ogiri-egusi is a condiment prepared from fermentation of Citrullus vulgaris (melon) seeds and consumed in many countries of West Africa. Its anti-oxidative and anti-hyperlipidaemic properties have been reported. This study investigated the anti-cancer activities of the aqueous and methanolic extracts from ogiri-egusi. Cytotoxicity was investigated using the MTT and colony-formation inhibition assays while flow-cytometer based Apopercentage assay was used to quantify apoptosis in extracts-treated cervical and liver cancer and normal human fibroblast cells. The inhibitory concentration responsible for killing 50% of cells after 24 h by the aqueous extract in KMST-6, HeLa, and Hep-G2 cells were estimated at 1.610, 1.020, and 1.507 mg/mL respectively. While these values reduced with increasing incubation time in cancer cells it increased in the non-cancer cell. Furthermore, the extract significantly induced apoptosis in HeLa (97 ± 0.18%) and Hep-G2 (73 ± 6.73%) cells. These findings were corroborated by cells morphologic presentations and inhibition of colony formation assay. These findings suggest that the aqueous extract from fermented Citrullus vulgaris seeds might be a nutraceutical with potential anti-cancer properties.

12 February 2022 in International Social Science Journal
Verified
Journal Article
Closed access
PDF file
AOAdedayo Olofinyehun
Adedayo Olofinyehun
AEAbiodun Egbetokun
Abiodun Egbetokun
AAAderonke Ayo‐Lawal
Aderonke Ayo‐Lawal
MSMaruf Sanni
Maruf Sanni
OOOmolayo Oluwatope
Omolayo Oluwatope
UYUtieyineshola Yusuff
Utieyineshola Yusuff

11 June 2022 in African Journal of Science, Technology, Innovation and Development
Verified
Journal Article
Closed access
RARachael Aderonke Ayo-Lawal
Rachael Aderonke Ayo-Lawal
CACaleb Muyiwa ADELOWO
Caleb Muyiwa ADELOWO
AOAyobami Adesina Oyewale
Ayobami Adesina Oyewale
EEEmmanuel Emeka Ejim-Eze
Emmanuel Emeka Ejim-Eze
EOElizabeth Adeteju Omimakinde
Elizabeth Adeteju Omimakinde
OUOkechukwu Ukwuoma
Okechukwu Ukwuoma
It is well known that innovation in the modern economy is driven by interactions among the stakeholders that make up the innovation system. Effective interactions among key actors in an innovation system foster flow of knowledge and resources development and commercialization of new products. This study assesses the depth of research and development (R&D) and level of interaction existing among key elements in the Nigerian pharmaceutical industry. Data were obtained from thirty-two manufacturing pharma firms, and sixty-nine researchers from faculties of pharmacy across Nigerian universities and three key research institutes with drug-related mandates. The results reveal poor synergy in research among the actors, and weak academia-industry interaction as only about one-third of industrial firms indicated active collaboration with knowledge institutions. More pertinently, over two-third of researchers in universities rated research-industry collaborations on most of the key aspects considered to be at least weak, Contract research and joint R&D activities were equally rated weak. The study concludes that the pharma innovation system in Nigeria requires serious government interventions by creating robust platform to promote productive interactions between these actors.